Human Microbiome Market is estimated to be US$ 3657.31 million by 2030 with a CAGR of 19.8% during the forecast period – By PMI Covina, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Human Microbiome is the genomic content of microbiota that inhabits a particular site in human body. They are present inside the surface of human body, for...

MatriSys Bioscience announces successful FDA Pre-IND review and Phase 2 plans for MSB-01, a revolutionary human-microbiome based treatment for Atopic Dermatitis SAN DIEGO, March 20, 2019 (GLOBE NEWSWIRE) -- MatriSys Bioscience, Inc., a clinical stage biotechnology company developing rationally designed microbiome therapeutics to treat the top five skin...